| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ACLX | Common Stock | Options Exercise | $56.5K | +8.48K | $6.66 | 8.48K | Nov 7, 2024 | Direct | ||
| transaction | ACLX | Common Stock | Sale | -$842K | -8.48K | -100% | $99.30 | 0 | Nov 7, 2024 | Direct | F1, F2 |
| transaction | ACLX | Common Stock | Options Exercise | $53.1K | +7.98K | $6.66 | 7.98K | Nov 8, 2024 | Direct | ||
| transaction | ACLX | Common Stock | Options Exercise | $387K | +25.8K | +323.31% | $15.00 | 33.8K | Nov 8, 2024 | Direct | |
| transaction | ACLX | Common Stock | Sale | -$588K | -5.9K | -17.47% | $99.60 | 27.9K | Nov 8, 2024 | Direct | F1, F3 |
| transaction | ACLX | Common Stock | Sale | -$209K | -2.08K | -7.45% | $100.57 | 25.8K | Nov 8, 2024 | Direct | F1, F4 |
| transaction | ACLX | Common Stock | Sale | -$2.72M | -25.8K | -100% | $105.46 | 0 | Nov 8, 2024 | Direct | F1, F5 |
| transaction | ACLX | Common Stock | Options Exercise | $229K | +15.2K | $15.00 | 15.2K | Nov 11, 2024 | Direct | ||
| transaction | ACLX | Common Stock | Sale | -$1.29M | -12.2K | -80.28% | $105.68 | 3.01K | Nov 11, 2024 | Direct | F1, F6 |
| transaction | ACLX | Common Stock | Sale | -$321K | -3.01K | -100% | $106.91 | 0 | Nov 11, 2024 | Direct | F1, F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ACLX | Stock Option (right to buy) | Options Exercise | $0 | -8.48K | -14.12% | $0.00 | 51.6K | Nov 7, 2024 | Common Stock | 8.48K | $6.66 | Direct | F8 |
| transaction | ACLX | Stock Option (right to buy) | Options Exercise | $0 | -7.98K | -15.47% | $0.00 | 43.6K | Nov 8, 2024 | Common Stock | 7.98K | $6.66 | Direct | F8 |
| transaction | ACLX | Stock Option (right to buy) | Options Exercise | $0 | -25.8K | -41.9% | $0.00 | 35.8K | Nov 8, 2024 | Common Stock | 25.8K | $15.00 | Direct | F9 |
| transaction | ACLX | Stock Option (right to buy) | Options Exercise | $0 | -15.2K | -42.62% | $0.00 | 20.5K | Nov 11, 2024 | Common Stock | 15.2K | $15.00 | Direct | F9 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. |
| F2 | Represents the weighted average share price of an aggregate total of 8,478 shares sold in the price range of $99.24 to $99.48 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Represents the weighted average share price of an aggregate total of 5,900 shares sold in the price range of $99.24 to $100.12 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F4 | Represents the weighted average share price of an aggregate total of 2,076 shares sold in the price range of $100.57 to $100.58 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F5 | Represents the weighted average share price of an aggregate total of 25,787 shares sold in the price range of $105.24 to $105.96 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F6 | Represents the weighted average share price of an aggregate total of 12,233 shares sold in the price range of $105.34 to $106.27 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F7 | Represents the weighted average share price of an aggregate total of 3,005 shares sold in the price range of $106.34 to $107.25 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F8 | Shares issued pursuant to the Issuer's 2017 Equity Incentive Plan (the "2017 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2017 Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean December 1, 2021. |
| F9 | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the shares subject to the option will vest each year following Equity Grant Date on the same day of the month as the Equity Grant Date (or, if there is no corresponding day in a particular month, then the last day of the month) over three (3) years. "Equity Grant Date" shall mean February 3, 2022. |